Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.8.3539

Targeting Tumor Metastasis by Regulating Nm23 Gene Expression  

Prabhu, V. Vinod (Department of Biotechnology, Karunya University)
Siddikuzzaman, Siddikuzzaman (Department of Biotechnology, Karunya University)
Grace, V.M. Berlin (Department of Biotechnology, Karunya University)
Guruvayoorappan, C. (Department of Biotechnology, Karunya University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.8, 2012 , pp. 3539-3548 More about this Journal
Abstract
The Nm23 gene is a metastatic suppressor identified in a melanoma cell line and expressed in different tumors where their levels of expression are associated with reduced or increased metastatic potential. Nm23 is one of the over 20 metastasis suppressor genes (MSGs) confirmed in vivo. It is highly conserved from yeast to human, implying a critical developmental function. Tumors with alteration of the p53 gene and reduced expression of the Nm23 gene are more prone to metastasis. Nm23-H1 has 3'-5' exonuclease activity. This review focuses on the role of Nm23 in cancer progression and also a potential novel target for cancer therapy.
Keywords
Nm23 gene; metastasis suppressor; tumor metastasis; MSGs; matrix metalloproteinase proteins;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Adams DG, Coffee RL, Zhang H, et al (2005). Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/ threonine phosphatase 2A holoenzymes. J Biol Chem, 30, 42644-54.
2 Almgren MA, Henriksson KC, Fujimoto J, Chang CL (2004). Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res, 2, 387-94.
3 Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, et al (1993). Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene, 8, 497-502.
4 Boissan M, De Wever O, Lizarraga F, et al (2010). Implication of metastasis suppressor nm23-h1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res, 70, 7710.
5 Boissan M, Wendum D, Arnaud-Dabernat S, (2005) . Increased lung metastasis in transgenic NM23-Null/SV40 micewith hepatocellular carcinoma. J Natl Cancer Inst, 97, 836-45.   DOI
6 Branca M, Giorgi C, Ciotti M (2006). Down-regulated nucleoside diphosphate kinase nm23-1 expression is unrelated to highrisk human papillomavirus but associated with progression of cervical intraepithelialneoplasia and unfavourable prognosis in cervical cancer. J Clin Pathol, 59, 1044-51.   DOI
7 Buxton IL, Yokdang N, Matz RM (2010). Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis. Cancer Lett, 28, 131-41.
8 Buxton ILO, Yokdang N (2011). Extracellular NM23 Signaling in breast cancer: incommodus verum. Cancers, 3, 2844-57   DOI
9 Carinci F, Arcelli D, Lo Muzio L, et al (2007). Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma. Transl Res, 150, 233-45.   DOI
10 Chambers AF, Naumov GN, Vantyghem SA, Tuck AB (2000). Molecular biology of breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res, 2, 400-7.   DOI
11 Chambers A, Groom A, MacDonald I (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Cancer Rev, 2, 563-72.   DOI
12 Chin-Shiu H, Ming-Kuei S, Cheng-Hung C, Miao-Lin H (2005). Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma SK-Hep-1 cells. J Nutr, 135, 2119-23.   DOI
13 Choi YJ, Cho SK, Hwang KC, et al (2009). Nm23-M5 mediates round and elongated spermatid survival by regulating GPX-5 levels. FEBS Lett, 17, 1292-8.
14 De La Rosa A, Williams RL, Steeg PS (1995). Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays, 17, 53-62.   DOI
15 Desvignes T, Pontarotti P, Fauvel C, Bobe J (2009). Nme protein family evolutionary history, a vertebrate perspective. BMC Evol Biol, 9, 256.
16 Fuhrman B, Volkova N, Rosenblat M, Aviram M (2000). Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal, 2, 491-506.   DOI   ScienceOn
17 Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J (2003). The tumor metastasis suppressor NM23-H1 is a granzyme A-activated DNase that nicks DNA during CTL-mediated apoptosis and the nucleosome assembly protein SET is its inhibitor. Cell, 112, 659-72.   DOI
18 Filiz G, Adim S, Aytacm B, Akar E, Vuruskan H (2010). Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma. J Int Med Res, 38, 620-4.   DOI   ScienceOn
19 Fournier HN, Albiges-Rizo C, Block MR (2003). New insights into Nm23 control of cell adhesion and migration. J Bioenerg Biomembr, 35, 81-7.   DOI
20 Gallagher BC, Parrott KA, Szabo G, De S Otero A (2003). Receptor activation regulatescortical, but not vesicular localization of NDP kinase. J Cell Sci, 116, 3239-50.   DOI
21 Gupta GP, Massague J (2006). Cancer metastasis: building a framework. Cell, 127, 679-95.   DOI   ScienceOn
22 Hamby CV, Abbi R, Prasad N, et al (2000). Backer Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Int J Cancer, 15, 547-53.
23 Hartsough MT, Clare SE, Mair M, et al (2001). Elevation of Breast Carcinoma Nm23-H1 Metastasis Suppressor Gene Expression and Reduced Motility by DNA Methylation Inhibition. Cancer Res, 61, 2320-7.
24 Howlett AR, Petersen OW, Steeg PS, Bissell MJ (2010). Novel function for the nm23-Hl gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. LBNL, 86, 1838-44.
25 Jung H, Seong HA, Ha H (2007). NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Chem, 30, 35293-307.
26 Ikeda T (2010). NDP kinase 7 is a conserved microtubule-binding protein preferentially expressed in ciliated cells. Cell Struct Funct, 13, 23-30.
27 Ishikawa N, Shimada N, Takagi Y, et al (2003). Molecular evolution of nucleoside diphosphate kinase genes: conserved core structures and multiple-layered regulatory regions. J Bioenerg. Biomembr, 35, 7-18.   DOI
28 Iwashita S, Fujii M, Mukai H, Ono Y, Miyamoto M (2004). Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem Biophys Res Commun, 6, 1063-8.
29 Kaetzel DM (2003). Transcription of the platelet-derived growth factor a-chain gene. Cytokine Growth Factor Rev, 14, 427-46.   DOI
30 Kaetzel DM, McCorkle JR, Novak M, Yang M, Jrrett, SG (2009). Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1. Mol Cell Biochem, 329, 161-5.   DOI
31 Kapoor S (2009). Nm23H1 expression and its role in the evolution of non-gastrointestinal malignancies. World J Gastroenterol, 28, 506-7.
32 Khan MH, Yasuda M, Higashino F, et al (2001). nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol, 158, 1785-91.   DOI
33 Kimura N, Shimada N, Fukuda M, et al (2000). Regulation of cellular functions by nucleoside diphosphate kinases in mammals. J Bioenerg Biomembr, 32, 309-15.   DOI
34 Lee JH, Marshall JC, Steeg PS, Horak CE (2009). Altered gene and protein expression by Nm23-H1 in metastasis suppression. Mol Cell Biochem, 329, 141-8.   DOI
35 Krishnan KS, Rikhy R, Rao R, et al (2001). Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron, 30, 197-210.   DOI
36 Kuppers DA, Lan K, Knight JS, Robertson ES (2005). Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. J Virol, 79, 9714-24.   DOI
37 Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000). The humanNm23/nucleosidediphosphate kinases. J Bioenerg Biomembr, 32, 247-58.   DOI
38 Lee MY, Jeong EJ, Oh JW, Choi KY (2009). NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway. Cancer Lett, 18, 221-6.
39 Levit MN, Abramczyk BM, Stock JB, Postel EH (2002). Interactions between Escherichia coli Nucleosidediphosphate Kinase and DNA. J Biol Chem, 277, 5163-7.   DOI
40 Li Y, Nie CJ, Hu L, et al (2010). Characterization of a novel mechanism of genomic instability involving the SEI1/SET/ NM23H1 pathway in esophageal cancers. Cancer Res, 15, 5695-705.
41 Li L, Chen LZ (2012). Factors influencing axillary lymph node metastasis in invasive breast cancer. Asian Pac J Cancer Prev, 13, 251-4.   DOI
42 Li Z, Xiang J, Zhang W, et al (2009). Nanoparticle delivery of antimetastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene Ther, 16, 423-9.   DOI
43 Lizuka N, Miyamoto K, Tangoku A, et al (2000).Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with $Na(^{+})$, $K(^{+})$-ATPase. Br J Cancer, 83, 1209-15.   DOI
44 Li J, Zhou J, Chen G, et al (2006) Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. Cancer Gene Ther, 13, 266-72.   DOI
45 Lin KH, Wang WJ, Wu YH, Cheng SY (2002). Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. Endocrinology, 143, 467-75.   DOI
46 Liu F, Zhang Y, Zhang XY, Chen HL (2002). Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metalloproteinase-2 and matrix metallopoproteinase-9 expression. J Cancer Res Clin Oncol, 128, 189-96.   DOI
47 Ma D, Xing Z, Liu B, et al (2002). NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem, 277, 1560-7.   DOI
48 MacDonald NJ, De La Rosa A, Benedict MA, et al (1993). A serine phosphorylation of nm23, and not its nucleoside disphosphat e kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem, 268, 25780-9.
49 Marshall JC, Collins J, Marino N, Steeg P (2010). The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer, 46, 1278-82.   DOI
50 Marshall JC, Lee JH, Steeg PS (2009). Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. Mol Cell Biochem, 329, 115-20.   DOI
51 Milon L, Meyer P, Chiadmi M, et al (2000). The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem, 12, 14264-72.
52 Marino N, Nakayama J, Collins JW, Steeg PS (2012). Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer Metastasis Rev. Jun 16. DOI 10.1007/s10555-012-9374-8. [Epub ahead of print].   DOI
53 Mathieu B, Dominique W, Arnaud-Dabernat S, et al (2005). increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst, 97, 836-45.   DOI
54 McDermott WG, Boissan M, Lacombe ML, Steeg PS, Horak CE (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis, 25, 131-8.   DOI
55 Mona A, Kandil MD, Monshira M, ABD El-Wahed MD (2000). The significance of metastasis related-factor nm23-Hi and cathepsin D in prostrate cancer. J Egyptian Nat Cancer Inst, 12, 199-210.
56 Munier A, Serres C, Kann ML, et al (2003). Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? Exp Cell Res, 1, 295-306.
57 Nakazawa Y, Arai H, Fujita N (2011). The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis. Cancer Res, 71, 1146-55.   DOI
58 Narayanan R, Ramaswami M (2003). Regulation of dynamin by nucleoside diphosphate kinase. J Bioenerg Biomembr, 35, 49-55.   DOI
59 Negroni A, Venturelli D, Tanno B, et al (2000). Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death Differ, 7, 843-50.   DOI
60 Otero AS (2000). NM23/nucleoside diphosphate kinase and signal transduction. J Bioenerg Biomembr, 32, 269-75.   DOI
61 Otsuki Y, Tanaka M, Yoshii S, et al (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA, 98, 4385-90.   DOI
62 Ouatas T, Halverson D, Steeg PS (2003). Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin Cancer Res, 9, 3763-72.
63 Palmieri D, Halverson DO, Ouatas T, et al (2005). Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptornegative breast cancer. J Natl Cancer Inst, 97, 632-42.   DOI
64 Parhar RS, Shi Y, Zou M, et al (1995). Effects of cytokine mediated modulation of Nm23 expression on the invasion and metastatic behavior of B16FlO melanoma cells. Int J Cancer, 60, 204-10.
65 Park HR, Kim SH, Lee SY, et al (2010). Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer, 117, 1864-73.
66 Postel EH, Berberich SJ, Rooney JW, Kaetzel DM (2000). Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr, 32, 277-84.   DOI
67 Postel EH, Zou X, Notterman DA, La Perle KM (2009). Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development. Mol Cell Biochem, 329, 45-50.   DOI
68 Raftopoulou M, Hall A (2004). Cell migration: Rho GTPases lead the way. Dev Biol, 265, 23-32.   DOI
69 Roberts PJ, Der CJ (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 14, 3291-310.
70 Rinker-Schaeffer JP, Keefe DR, Welch D (2006). Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin Cancer Res, 13, 3882-9.
71 Roymans D, Vissenberg K, De Jonghe C, et al (2001). Identification of the tumor metastasis suppressor Nm23-H1/ Nm23-R1 as a constituent of the centrosome. Exp Cell Res, 15, 145-53.
72 Sadek CM, Damdimopoulos AE, Pelto-Huikko M, et al (2001). Sptrx-2, a fusion protein composed of one thioredoxin and three tandemly repeated NDP-kinase domains is expressed in human testis germ cells. Genes Cells, 6, 1077-90.   DOI
73 Seong HA, Jung H, Ha H (2007). NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptorassociated protein, a transforming growth factor-beta (TGFbeta) receptor-interacting protein, and negatively regulates TGF-beta signaling. J Biol Chem, 282, 12075-96.   DOI
74 She S, Xu B, He M, Lan X, Wang Q (2010). Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1. J Exp Clin Cancer Res, 11, 29-93.
75 Siclari VA, Guise TA, Chirgwin JM (2006). Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer metastasis Rev, 25, 621-33.
76 Siddikuzzaman, Grace VM, Guruvayoorappan C (2011). Lysyl oxidase: a potential target for cancer therapy. Inflammopharmacology, 19, 117-29.   DOI
77 Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (2002). Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA, 3, 11593-8.
78 Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, et al (2005). Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol, 79, 42-50.   DOI
79 Sies H, Stahl W (2003). Non-nutritive bioactive constituents of plants: lycopene, lutein and zeaxanthin. Int J Vitam Nutr Res, 73, 95-100.   DOI
80 Simonsson T, Pribylova M, Vorlickova M (2000). A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures. Biochem Biophys Res Commun, 11,158-66.
81 Sossey-Alaoui K, Safina A, Li X, et al (2007). Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol, 170, 2112-21.   DOI
82 Sporn MB (1996). The war on cancer. Lancet, 347, 1377-81.   DOI   ScienceOn
83 Stafford LJ, Vaidya KS, Welch DR (2008). Metastasis suppressors genes in cancer. Int J Biochem Cell Biol, 40, 874-91.   DOI   ScienceOn
84 Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB et al (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 24, 200-4.
85 Steeg PS (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med, 12, 895-904.   DOI
86 Steeg PS, Horak CE, Miller KD (2008). Clinical-translational approaches to the Nm23-H1 metastasis suppressor. Clin Cancer Res, 14, 5006-12.   DOI
87 Steeg P (2003). Metastasis suppressors alter the signal transduction of cancer cells. Nat Cancer Rev, 3, 55-63.   DOI
88 Thakur RK, Kumar PL, Halder K, et al (2009). Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res, 37, 172-83.   DOI
89 Syed V, Mukherjee K, Lyons-Weiler J, et al (2005). Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene, 3, 1774-87.
90 Tagashira H, Hamazaki K, Tanaka N, Gao C, Namba M (1998). Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (colon 26 line) transfected with nm23-2 rat nucleoside diphosphate kinase a isoform. Int J Mol Med, 2, 65-8.
91 Tomita M, Ayabe T, Matsuzaki Y, Onitsuka T (2001). Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients. Eur J Cardiothorac Surg, 19, 904-7.   DOI
92 Townson JL, Chambers AF (2006). Dormancy of solitary metastatic cells. Cell Cycle, 5, 1744-50.   DOI
93 Tsuiki H, Nitta M, Furuya A, et al (1999). A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. J Cell Biochem, 76, 254-69.
94 Valentijn LJ, Koster J, Versteeg R (2006). Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Genomics, 87, 483-9.   DOI
95 Venturelli D, Cesi V, Ransac S, et al (2000). The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells. Exp Cell Res, 15, 265-71.
96 Wagner PD, Steeg PS, Vu ND (1997). Two-component kinaselike activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA, 94, 9000-5.   DOI
97 Yu LG, Packman LC, Weldon M, Hamlett J, Rhodes JM (2004). Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the anti-proliferative lectin. Jacalin J Biol Chem, 1, 41377-83.
98 Wang YF, Chow KC, Chang SY (2004). Prognostic significance of nm23-1 expression in oral squamous cell carcinoma. Br J Cancer, 90, 2186-93.   DOI
99 Wang HM, Wang J (2012). Expression of Tiam1 in lung cancer and its clinical significance. Asian Pac J Cancer Prev, 13, 613-5.   DOI   ScienceOn
100 Webb PA, Perisic O, Mendola CE, Backer JM, Williams RL (1995). The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. J Mol Biol, 25, 574-87.
101 Zajac-Kaye M (2001). Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer, 34, 43-6.   DOI   ScienceOn
102 Zhang Q, McCorkle JR, Novak M, et al (2011). Metastasis suppressor function of NM23-H1 requires its 30-50 exonuclease activity. Int J Cancer, 128, 40-50.   DOI
103 Ziaei JE, Pourzand A, Bayat A, Vaez J (2012). Patterns of metastasis and survival in breast cancer patients: a preliminary study in an Iranian population. Asian Pac J Cancer Prev, 13, 937-40.   DOI   ScienceOn